Erez Aminov - Nov 19, 2024 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Signature
/s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov
Stock symbol
MIRA
Transactions as of
Nov 19, 2024
Transactions value $
-$133,649
Form type
4
Date filed
11/27/2024, 04:15 PM
Previous filing
Aug 29, 2024
Next filing
Dec 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRA Common Stock Sale -$77K -55.4K -4.77% $1.39 1.11M Nov 19, 2024 Direct F1, F2
transaction MIRA Common Stock Sale -$56.6K -44.6K -4.03% $1.27 1.06M Nov 20, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.